These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 18455802)

  • 1. Thyroid hormone and "cardiac metamorphosis": potential therapeutic implications.
    Pantos C; Mourouzis I; Xinaris C; Papadopoulou-Daifoti Z; Cokkinos D
    Pharmacol Ther; 2008 May; 118(2):277-94. PubMed ID: 18455802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyroid hormone as a therapeutic option for treating ischaemic heart disease: from early reperfusion to late remodelling.
    Pantos C; Mourouzis I; Cokkinos DV
    Vascul Pharmacol; 2010; 52(3-4):157-65. PubMed ID: 19951746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid hormone and cardiac repair/regeneration: from Prometheus myth to reality?
    Pantos C; Mourouzis I; Cokkinos DV
    Can J Physiol Pharmacol; 2012 Aug; 90(8):977-87. PubMed ID: 22762197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term thyroid hormone administration reshapes left ventricular chamber and improves cardiac function after myocardial infarction in rats.
    Pantos C; Mourouzis I; Markakis K; Tsagoulis N; Panagiotou M; Cokkinos DV
    Basic Res Cardiol; 2008 Jul; 103(4):308-18. PubMed ID: 18274800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New insights into the role of thyroid hormone in cardiac remodeling: time to reconsider?
    Pantos C; Mourouzis I; Cokkinos DV
    Heart Fail Rev; 2011 Jan; 16(1):79-96. PubMed ID: 20668933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translating thyroid hormone effects into clinical practice: the relevance of thyroid hormone receptor α1 in cardiac repair.
    Pantos C; Mourouzis I
    Heart Fail Rev; 2015 May; 20(3):273-82. PubMed ID: 25501869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential novel pharmacological therapies for myocardial remodelling.
    Landmesser U; Wollert KC; Drexler H
    Cardiovasc Res; 2009 Feb; 81(3):519-27. PubMed ID: 19019834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Thyroid hormones and the heart].
    Zyśko D
    Pol Merkur Lekarski; 1999 Mar; 6(33):157-60. PubMed ID: 10365603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyroid hormone receptor alpha 1: a switch to cardiac cell "metamorphosis"?
    Pantos C; Xinaris C; Mourouzis I; Perimenis P; Politi E; Spanou D; Cokkinos DV
    J Physiol Pharmacol; 2008 Jun; 59(2):253-69. PubMed ID: 18622044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyroid hormone and myocardial ischaemia.
    Pantos C; Mourouzis I; Xinaris C; Cokkinos DV
    J Steroid Biochem Mol Biol; 2008 Apr; 109(3-5):314-22. PubMed ID: 18430565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Thyroid hormones and their action on the myocardium].
    Cokkinos DV; Pantos C
    Bull Acad Natl Med; 2009 Feb; 193(2):327-36; discussion 336-8. PubMed ID: 19718890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid hormone at supra-physiological dose optimizes cardiac geometry and improves cardiac function in rats with old myocardial infarction.
    Pantos C; Mourouzis I; Tsagoulis N; Markakis K; Galanopoulos G; Roukounakis N; Perimenis P; Liappas A; Cokkinos DV
    J Physiol Pharmacol; 2009 Sep; 60(3):49-56. PubMed ID: 19826181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanisms of mineralocorticoid receptor-mediated cardiac fibrosis and vascular inflammation.
    Young MJ
    Curr Opin Nephrol Hypertens; 2008 Mar; 17(2):174-80. PubMed ID: 18277151
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thyroid hormone and phenotypes of cardioprotection.
    Pantos C; Malliopoulou V; Varonos DD; Cokkinos DV
    Basic Res Cardiol; 2004 Mar; 99(2):101-20. PubMed ID: 14963669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac fibroblasts: at the heart of myocardial remodeling.
    Porter KE; Turner NA
    Pharmacol Ther; 2009 Aug; 123(2):255-78. PubMed ID: 19460403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rebuilding the post-infarcted myocardium by activating 'physiologic' hypertrophic signaling pathways: the thyroid hormone paradigm.
    Pantos C; Mourouzis I; Cokkinos DV
    Heart Fail Rev; 2010 Mar; 15(2):143-54. PubMed ID: 18773293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomics in cardiac metabolism.
    Samuel JL; Schaub MC; Zaugg M; Mamas M; Dunn WB; Swynghedauw B
    Cardiovasc Res; 2008 Jul; 79(2):218-27. PubMed ID: 18326557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Role of thyroid hormones in regulation of heart function].
    Telkova IL; Karpov RS
    Klin Med (Mosk); 2004; 82(1):12-8. PubMed ID: 15022589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential therapeutic applications of thyroid hormone analogs.
    Brenta G; Danzi S; Klein I
    Nat Clin Pract Endocrinol Metab; 2007 Sep; 3(9):632-40. PubMed ID: 17710084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotoxicosis and the heart--a review of the literature.
    Kolawole BA; Balogun MO
    Niger J Med; 2001; 10(2):50-4. PubMed ID: 11705057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.